Azenta (AZTA) Net Equity Issued and Repurchased (2010 - 2026)
Azenta (AZTA) posted quarterly Net Equity Issued and Repurchased of $1.2 million for Q1 2026, down 3.12% quarter-over-quarter from $1.2 million in Q3 2025.
Azenta (AZTA) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Net Equity Issued and Repurchased for 15 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.0 million (changed N/A YoY), while the FY2025 annual figure was $2.8 million, down 15.52% from the prior year.
- Net Equity Issued and Repurchased slipped to $1.2 million in Q1 2026 per AZTA's latest filing, from $1.2 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $1.8 million in Q3 2022 and bottomed at $1.2 million in Q1 2026.
- Historically, Net Equity Issued and Repurchased has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased plunged 44.75% — and 2023, when it slipped 0.84%.
- Azenta's Net Equity Issued and Repurchased stood at $1.8 million in 2022, then decreased by 0.84% to $1.8 million in 2023, then dropped by 9.5% to $1.6 million in 2024, then slipped by 23.99% to $1.2 million in 2025, then retreated by 3.12% to $1.2 million in 2026.
- Business Quant data shows AZTA's Net Equity Issued and Repurchased at $1.2 million in Q1 2026, $1.2 million in Q3 2025, and $1.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 29.31 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Sep 30, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.23 Mn |
| Sep 30, 2020 | 2.26 Mn |
| Sep 30, 2020 | 2.26 Mn |
| Jun 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Sep 30, 2019 | 1.87 Mn |
| Sep 30, 2019 | 1.87 Mn |